Search results
Results From The WOW.Com Content Network
List of largest biomedical companies by revenue. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$ 10 billion, ranked by their revenue in the respective financial year. It does not include biotechnology companies that ...
Usana Health Sciences, Inc., or USANA, is an American direct-selling company based in West Valley City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. [3] The company manufactures most of its nutritional products, dietary supplements, and skincare products at a West Valley City facility. Its ...
September 12, 2024 at 6:11 PM. There was some good news in the clinical sphere for Gilead Sciences (NASDAQ: GILD) on Thursday, and this drove its stock price up by almost 3% that trading session ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Immunovant is a member of the Roivant Sciences Ltd. (NASDAQ:ROIV) family of companies. Also Read: Vivek Ramaswamy-Founded Roivant’s Anti-Inflammatory Drug Aces Mid-Stage Study .
The stock of Usana Health Sciences (NYSE:USNA, 30-year Financials) appears to be fairly valued, according to GuruFocus Value calculation.
Exact Sciences Corp. is a molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer ; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer .
ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. [2] As of June 2023, ICON had approximately 41,160 employees in 108 locations spread across 53 countries.